Caly Chien
Impact in
- Hepatology top 1%
- Hepatitis C virus research
- Virology top 5%
- HIV Research and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 11
- Oncology 10
- Colorectal Cancer Treatments and Studies 4
- Co-authors
- Dennis M. Grasela (3 shared papers)Richard E. Nettles (2 shared papers)Richard J. Colonno (2 shared papers)Nicholas A. Meanwell (2 shared papers)Lawrence B. Snyder (1 shared paper)Makonen Belema (1 shared paper)David R. Langley (1 shared paper)Jin-Hua Sun (1 shared paper)
- Journals
- The Journal of Clinical Pharmacology (4 papers)Journal of Clinical Oncology (3 papers)Clinical Cancer Research (3 papers)Cancer Chemotherapy and Pharmacology (3 papers)Clinical Pharmacokinetics (3 papers)
- Partner nations
- United StatesBelgiumCanada
In The Last Decade
Caly Chien
34 papers receiving 1.5k citations
Caly Chien's Hit Papers
Peers
Comparison fields: 5 of 90
- Hepatology 574
- Virology 82
- Infectious Diseases 230
- Epidemiology 394
- Pulmonary and Respiratory Medicine 259
Countries citing papers authored by Caly Chien
This map shows the geographic impact of Caly Chien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caly Chien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caly Chien more than expected).
Fields of papers citing papers by Caly Chien
This network shows the impact of papers produced by Caly Chien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caly Chien. The network helps show where Caly Chien may publish in the future.
Co-authors
The 25 scholars most cited alongside Caly Chien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect Hit paper breakdown → | 2010 | 693 |
| 2 | 2015 | 97 | |
| 3 | 2015 | 83 | |
| 4 | 2002 | 61 | |
| 5 | 2015 | 51 | |
| 6 | 2001 | 48 | |
| 7 | 2013 | 44 | |
| 8 | 2018 | 42 | |
| 9 | 2020 | 42 | |
| 10 | 2012 | 41 | |
| 11 | 2004 | 36 | |
| 12 | 2021 | 32 | |
| 13 | 2014 | 29 | |
| 14 | 2019 | 29 | |
| 15 | 2013 | 23 | |
| 16 | 2018 | 22 | |
| 17 | 2020 | 17 | |
| 18 | 2019 | 17 | |
| 19 | 2020 | 16 | |
| 20 | 2014 | 15 |
About Caly Chien
Caly Chien is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Genetics, having authored 36 papers that have together received 1.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (11 papers), Neuroendocrine regulation and behavior (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Maternal Mental Health During Pregnancy and Postpartum (3 papers). The work is most often cited by research in Hepatology (574 citations), Virology (82 citations), Infectious Diseases (230 citations), Epidemiology (394 citations) and Pulmonary and Respiratory Medicine (259 citations). Caly Chien has collaborated with scholars based in United States, Belgium and Canada. Frequent co-authors include Dennis M. Grasela, Richard E. Nettles, Richard J. Colonno, Nicholas A. Meanwell, Lawrence B. Snyder, Makonen Belema, David R. Langley, Jin-Hua Sun, Donald R. O’Boyle and Jay O. Knipe. Their work appears in journals such as The Journal of Clinical Pharmacology, Journal of Clinical Oncology, Clinical Cancer Research, Cancer Chemotherapy and Pharmacology and Clinical Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.